Literature DB >> 6823505

Investigation of circular asymmetry in cancer mortality of Hiroshima and Nagasaki A-bomb survivors.

A V Peterson, R L Prentice, T Ishimaru, H Kato, M Mason.   

Abstract

Data on Hiroshima and Nagasaki A-bomb survivors are used to investigate, for each city, possible circular asymmetry in cancer mortality around the hypocenter. Using the Cox regression method and controlling for age ATB, sex, followup year, distance from the hypocenter, and type of shielding, it is found that in Hiroshima cancer mortality was significantly higher in the westerly direction from the hypocenter. Mortality from stomach cancer, leukemia, and colon cancer were higher in the westerly direction. In Nagasaki, only lung cancer exhibited circular asymmetry, and was significantly higher in the westerly direction. For various reasons, the results tend to support the possibility of an asymmetry in radiation dose in Hiroshima, but not in Nagasaki. Also, possible asymmetry in nondose variables associated with cancer is suggested in both cities, particularly in variables associated with lung cancer. Indications for future work and implications for future dose-mortality investigations are discussed.

Entities:  

Mesh:

Year:  1983        PMID: 6823505

Source DB:  PubMed          Journal:  Radiat Res        ISSN: 0033-7587            Impact factor:   2.841


  2 in total

1.  Gamma-ray thermoluminescence measurements: a record of fallout deposition in Hiroshima?

Authors:  Stephen D Egbert; George D Kerr
Journal:  Radiat Environ Biophys       Date:  2012-03-16       Impact factor: 1.925

2.  Investigation on circular asymmetry of geographical distribution in cancer mortality of Hiroshima atomic bomb survivors based on risk maps: analysis of spatial survival data.

Authors:  Tetsuji Tonda; Kenichi Satoh; Keiko Otani; Yuya Sato; Hirofumi Maruyama; Hideshi Kawakami; Satoshi Tashiro; Masaharu Hoshi; Megu Ohtaki
Journal:  Radiat Environ Biophys       Date:  2012-05       Impact factor: 1.925

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.